Redpharm Drug
Product Images NDC 67296-0769

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Redpharm Drug (NDC 67296-0769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B5387e98-figure-01 (B5387e98 Figure 01)

Chemical structure of the active ingredient shown in the image, featuring a benzene ring with hydroxyl groups and a side chain containing a tri-methyl-substituted amine, displayed with two sulfuric acid molecules as part of the compound.*

FDA Label Image

B5387e98-figure-02 (B5387e98 Figure 02)

Chemical structure of an active ingredient showing a bicyclic amine with a quaternary ammonium ion, a hydroxyl group, a benzyl ester, and bromide hydrate (Br•H2O) on the right side.*

FDA Label Image

B5387e98-figure-03 (B5387e98 Figure 03)

A line graph showing the volume in liters over time after dosing, measured in hours, for three inhalation drugs: Albuterol, Ipratropium, and a combination of Ipratropium Bromide and Albuterol Sulfate inhalation solution. The graph tracks lung function changes over 8 hours.*

FDA Label Image

B5387e98-figure-04 (B5387e98 Figure 04)

A data table listing adverse events occurring in greater than or equal to 1% of more than one treatment group, highlighting the highest percentage in the combination treatment with ipratropium bromide and albuterol sulfate. It compares the number and percentage of patients experiencing adverse events across three groups: Albuterol, Ipratropium, and their combination, categorized by body system and specific event, such as pain, diarrhea, bronchitis, and urinary tract infection.*

FDA Label Image

B5387e98-figure-05 (B5387e98 Figure 05)

An instructional diagram labeled Figure 1 showing the use of a dropper bottle with a dropper being positioned above the bottle opening and a small container next to it. The illustration likely demonstrates the process of dispensing liquid from the dropper into the container.*

FDA Label Image

B5387e98-figure-06 (B5387e98 Figure 06)

An instructional illustration showing how to attach a small device or component to a tube or nozzle. The image highlights the connection step where the component is aligned to fit onto the tube end.*

FDA Label Image

B5387e98-figure-07 (B5387e98 Figure 07)

An instructional illustration showing a side view of a person using a handheld inhaler device. The person's mouth is placed on the inhaler mouthpiece, with one hand supporting the device. Labeled as Figure 3, it demonstrates proper inhaler use technique.*

FDA Label Image

B5387e98-figure-08 (B5387e98 Figure 08)

An instructional illustration showing a person using a nasal spray bottle. The image depicts the proper positioning to administer the spray into a nostril, with a hand holding the spray device and the nostril clearly visible.*

FDA Label Image

Figure 09 (B5387e98 Figure 09)

Label for RedPharm Drug inhalation solution containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg per 3 mL vial. The package includes 5 sterile unit-dose vials intended for oral inhalation only. The product is manufactured by Nephron Pharmaceuticals Corporation and includes storage and usage instructions along with a barcode.*

FDA Label Image

Figure 10 (B5387e98 Figure 10)

The image shows a flattened carton for an inhalation solution labeled Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg. The packaging indicates it is for oral inhalation only, supplied in 30 x 3 mL sterile unit-dose vials. The label includes storage instructions and a barcode. The manufacturer or labeler is Nephron. The NDC on the carton is 0487-0201-03.*

FDA Label Image

Figure 11 (B5387e98 Figure 11)

Packaging label for Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg inhalation solution in sterile unit-dose vials. The label states it is for oral inhalation only, with NDC 0487-0201-60. The label includes dosing and storage instructions and is marked as Rx only. The labeler is Nephron Pharmaceuticals, with a logo shown on the box.*

FDA Label Image

Figure 12 (B5387e98 Figure 12)

This image shows patient instructions and drug information for an inhalation solution containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg per 3 mL unit-dose vial. It includes directions for use, storage conditions, dosage recommendations, manufacturer contact details, and a barcode.*

FDA Label Image

Figure 13 (B5387e98 Figure 13)

Packaging label for Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg inhalation solution. The label indicates the product is for oral inhalation only and is provided as 30 sterile unit-dose vials of 3 mL each, manufactured by Nephron. The label includes administration instructions, a drug usage graph, and a table with pharmacokinetic data. The product is Rx only.*

FDA Label Image

Figure 14 (B5387e98 Figure 14)

The image shows an unfolded carton packaging for RedPharm Drug by RedPharm Drug. The carton includes detailed text panels and chemical structure diagrams on the flaps, with an overall layout designed for folding into a box. No specific dosage form, strength, or package count is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.